8-K: Centrus Energy Corp. Reports Strong 2024 Results Driven by Revenue Growth and Strategic Initiatives

Centrus Energy Corp. announces positive financial results for 2024, marked by increased revenue, strategic investments, and key contract wins in the nuclear fuel sector.

Summary

• Centrus Energy Corp. reported its 2024 financial results, showcasing a year of growth and strategic advancements.
• The company's full-year revenue reached $442.0 million, compared to $320.2 million in the previous year.
• Gross profit for 2024 was $111.5 million, slightly lower than the $112.1 million reported in 2023.
• Net income for the year stood at $73.2 million, or $4.49 per basic share and $4.47 per diluted share, compared to $84.4 million in the prior year.
• Centrus strengthened its balance sheet by closing $402.5 million in convertible senior notes, resulting in an unrestricted cash balance of $671.4 million as of December 31, 2024.
• The company announced an investment of approximately $60.0 million in centrifuge manufacturing activities at Oak Ridge, Tennessee.
• Centrus was selected as a U.S. Department of Energy (DOE) contract awardee for low-enriched uranium (LEU) and high-assay low-enriched uranium (HALEU) production and HALEU Deconversion.
• The company's backlog as of December 31, 2024, is $3.7 billion, extending to 2040.
• The LEU segment backlog is approximately $2.8 billion, including contingent LEU sales contracts and commitments.
• The Technical Solutions segment backlog is approximately $0.9 billion.

Sentiment

Score: 7

Explanation: The document presents a generally positive outlook with strong revenue growth and strategic contract wins, but the decrease in net income and gross profit for the LEU segment tempers the overall sentiment.

Positives

• Revenue increased significantly to $442.0 million, driven by growth in both LEU and Technical Solutions segments.
• The company strengthened its financial position with a $402.5 million convertible senior notes offering, increasing its cash balance.
• Centrus secured multiple DOE contracts for LEU and HALEU production, indicating strong government support.
• The company is investing in centrifuge manufacturing to de-risk the supply chain and accelerate deployment.
• Strategic initiatives related to defined benefit pension plans resulted in a reduction of $277.5 million in pension obligations and the recognition of $16.8 million in actuarial gains.
• The IRS granted a $62.4 million credit allocation for the manufacturing facility in Oak Ridge.
• The company signed an agreement with Korea Hydro & Nuclear Power (KHNP) definitizing $0.8 billion of contingent commitments.

Negatives

• Gross profit decreased slightly to $111.5 million from $112.1 million in the previous year.
• Net income decreased to $73.2 million from $84.4 million in the prior year.
• Gross profit for the LEU segment decreased by $11.2 million (or 11%), primarily due to a decrease in margin on SWU sales resulting from the specific contract and pricing mix of SWU contracts.
• A single customer with a loss contract was responsible for 87% of the decrease in SWU gross margin.

Risks

• The company faces risks related to geopolitical conflicts and potential sanctions impacting its ability to obtain and deliver LEU.
• There are risks associated with laws banning or restricting imports of Russian LEU into the U.S.
• Centrus faces uncertainty regarding its ability to secure additional waivers from the Import Ban Act.
• The company is subject to risks related to TENEX's ability to deliver LEU due to potential sanctions or Russian government actions.
• There are risks related to government funding for HALEU and LEU programs and the potential impact of Executive Order 14154.
• The company faces risks related to the increasing quantities of LEU being imported into the United States from China and the impact on our ability to make future LEU or SWU sales or ability to finance any build out of our enrichment capacities.
• The company faces risks related to the DOE not issuing any task orders to any contract awardee under any of the HALEU Production Contract, LEU Production Contract, or HALEU Deconversion Contract or not issuing any task orders to the Company under any of those contracts.

Future Outlook

Centrus is well-positioned to compete for more than $3.4 billion in federal funding and aims to expand its enrichment plant in Ohio. The company anticipates meeting vital needs in the nuclear industry, including filling the void from the enriched uranium ban and powering data centers and AI technologies.

Management Comments

• This was another strong quarter and year for Centrus as we expanded our backlog, demonstrated the success of our technology by continuing first-of-a-kind HALEU production, and restarted centrifuge manufacturing activities, said Centrus President and CEO Amir Vexler.
• As the only U.S.-owned, U.S.-technology enrichment company, we are well-positioned to compete for more than $3.4 billion in federal funding that has been approved by Congress and uniquely positioned to deliver a made-in-America solution that supports American jobs.

Industry Context

The announcement comes amid rising momentum for the nuclear industry, driven by the upcoming enriched uranium ban, mothballed reactors returning online, and the energy demands of data centers and AI technologies. Centrus aims to capitalize on these trends by expanding its production capabilities and securing government contracts.

Comparison to Industry Standards

• It is difficult to make a direct comparison to industry standards without specific competitor data, but Centrus's focus on HALEU production aligns with the growing demand for advanced reactor fuels.
• Companies like Orano and Urenco are major players in the uranium enrichment market, and Centrus is positioning itself to compete with them, particularly in the U.S. market.
• The $3.7 billion backlog indicates strong demand for Centrus's products and services, suggesting a competitive position in the industry.
• The company's focus on domestic production and U.S. technology gives it a strategic advantage in securing government contracts and meeting national security needs.

Stakeholder Impact

• Shareholders will benefit from the company's revenue growth and strategic investments.
• Employees will see potential job creation and stability through the expansion of manufacturing activities.
• Customers will have access to a reliable supply of nuclear fuel components and services.
• The company's activities support clean energy, energy security, and national security needs.

Next Steps

• Centrus will continue to produce HALEU at its American Centrifuge Operating (ACO) Plant in Piketon, Ohio.
• The company will compete for task orders under the HALEU Production Contract, LEU Production Contract, and HALEU Deconversion Contract.
• Centrus intends to use the net proceeds from the offering for general working capital and corporate purposes, which may include investment in technology development or deployment, repayment or repurchase of outstanding debt, capital expenditures, potential acquisitions and other business opportunities and purposes.
• TENEX has informed Centrus of its plan to seek additional export licenses to meet its delivery obligations under the TENEX Supply Contract for our other pending and future orders.

Key Dates